Literature DB >> 455247

Estrogen receptor values in patients with benign breast disease.

J C Allegra, M E Lippman, L Green, A Barlock, R Simon, E B Thompson, K K Huff, W Griffin.   

Abstract

Tissue specimens from 55 female patients with benign breast disease were assayed for estrogen receptor. Twenty-one of 55 patients (38%) had tumors which contained significant amounts of estrogen receptor (greater than 10 femtomoles/mg protein). Fibroadenomas possessed estrogen receptor more frequently than fibrocystic disease or other benign breast tumors. Estrogen receptor positivity did not correlate with laterality of the tumor; location or size of the largest nodule. Patients with estrogen receptor positive tumors had a mean age of 26.9 years compared to 36.4 years for patients with estrogen receptor negative tumors (p less than 0.01). Twenty of 46 (43%) premenopausal patients had benign tumors which were estrogen receptor positive compared to zero of 8 postmenopausal patients (p less than 0.05).

Entities:  

Mesh:

Substances:

Year:  1979        PMID: 455247     DOI: 10.1002/1097-0142(197907)44:1<228::aid-cncr2820440137>3.0.co;2-0

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Steroid receptors in breast cancer: sources of inter-laboratory variation in dextran-charcoal assays.

Authors:  S M Thorpe
Journal:  Breast Cancer Res Treat       Date:  1987       Impact factor: 4.872

2.  Estrogen receptor expression in atypical hyperplasia: lack of association with breast cancer.

Authors:  Fritcher Emily G Barr; Amy C Degnim; Lynn C Hartmann; Derek C Radisky; Judy C Boughey; Stephanie S Anderson; Robert A Vierkant; Marlene H Frost; Daniel W Visscher; Carol Reynolds
Journal:  Cancer Prev Res (Phila)       Date:  2011-01-05

Review 3.  Epidemiology and endocrinology of benign breast disease.

Authors:  D Y Wang; I S Fentiman
Journal:  Breast Cancer Res Treat       Date:  1985       Impact factor: 4.872

4.  Effects of danazol on incidence of progesterone and oestrogen receptors in benign breast disease.

Authors:  C Panahy; J R Puddefoot; E Anderson; G P Vinson; C L Berry; M J Turner; C L Brown; A W Goode
Journal:  Br Med J (Clin Res Ed)       Date:  1987-08-22

Review 5.  Estrogen receptor variants.

Authors:  T A Hopp; S A Fuqua
Journal:  J Mammary Gland Biol Neoplasia       Date:  1998-01       Impact factor: 2.673

Review 6.  Benign breast diseases.

Authors:  Carine Courtillot; Geneviève Plu-Bureau; Nadine Binart; Corinne Balleyguier; Brigitte Sigal-Zafrani; Vincent Goffin; Frédérique Kuttenn; Paul A Kelly; Philippe Touraine
Journal:  J Mammary Gland Biol Neoplasia       Date:  2005-10       Impact factor: 2.673

Review 7.  Biological features of premalignant disease in the human breast.

Authors:  D C Allred; S K Mohsin
Journal:  J Mammary Gland Biol Neoplasia       Date:  2000-10       Impact factor: 2.673

8.  Expression of the estrogen receptor gene in developing and adult human breast.

Authors:  M Boyd; R H Hildebrandt; S A Bartow
Journal:  Breast Cancer Res Treat       Date:  1996       Impact factor: 4.872

9.  Isothiocyanates repress estrogen receptor alpha expression in breast cancer cells.

Authors:  Lianguo Kang; Ling Ding; Zhao-Yi Wang
Journal:  Oncol Rep       Date:  2009-01       Impact factor: 3.906

10.  Expression of ER, Ki-67 and cylinD1 in the pre-cancerous breast of Chinese patients.

Authors:  Cheng-Jun Zhou; Qing-Hui Zhang; Ting-Guo Zhang; Shan-Zhen Sun; Hong Li; Yan Wang; Zhi-Yan Liu
Journal:  Pathol Oncol Res       Date:  2008-10-22       Impact factor: 3.201

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.